. (SNTA)
- - (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
. (SNTA)
-
- (-)
Market Cap: -
As of 12/31/69 07:00 PM EST. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
-
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Lynch Brian Joseph | SVP and General Counsel | Jan 16, 2024 | Option Exercise | $243.92 | 949 | 231,480 | 14,052 | Jan 18, 2024, 01:52 PM |
FRIEDMAN PAUL A | Director | Jan 16, 2023 | Option Exercise | $243.92 | 2,254 | 549,796 | 20,001 | Jan 18, 2024, 01:47 PM |
Taub Rebecca | Pres., R&D, and CMO | Jan 16, 2024 | Option Exercise | $243.92 | 1,546 | 377,100 | 15,001 | Jan 18, 2024, 01:46 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Jan 16, 2024 | Option Exercise | $243.92 | 550 | 134,156 | 5,117 | Jan 18, 2024, 01:45 PM |
Howarth Alex G. | Chief Financial Officer | Jan 16, 2024 | Option Exercise | $243.92 | 1,067 | 260,263 | 13,934 | Jan 18, 2024, 01:39 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 15, 2023 | Option Exercise | $87.92 | 2,000 | 175,840 | 7,667 | Dec 18, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 14, 2023 | Option Exercise | $87.92 | 2,000 | 175,840 | 7,667 | Dec 18, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 14, 2023 | Sale | $232.50 | 2,000 | 465,000 | 6,667 | Dec 18, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 15, 2023 | Sale | $238.50 | 2,000 | 477,000 | 6,667 | Dec 18, 2023, 04:30 PM |
BAKER BROS. ADVISORS LP | Director | Dec 14, 2023 | Buy | $228.32 | 20,633 | 4,710,893 | 1,793,403 | Dec 14, 2023, 06:10 PM |
BAKER BROS. ADVISORS LP | Director | Dec 13, 2023 | Buy | $219.39 | 81,159 | 17,805,684 | 1,774,294 | Dec 14, 2023, 06:10 PM |
BAKER BROS. ADVISORS LP | Director | Dec 12, 2023 | Buy | $218.31 | 34,578 | 7,548,616 | 1,699,129 | Dec 14, 2023, 06:09 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 13, 2023 | Option Exercise | $87.92 | 2,500 | 219,800 | 8,167 | Dec 14, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 12, 2023 | Option Exercise | $87.92 | 1,300 | 114,296 | 6,967 | Dec 14, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 13, 2023 | Sale | $225.40 | 2,500 | 563,500 | 6,667 | Dec 14, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Dec 12, 2023 | Sale | $217.85 | 1,300 | 283,200 | 6,467 | Dec 14, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 05, 2023 | Option Exercise | $87.09 | 1,000 | 87,090 | 16,001 | Dec 06, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 04, 2023 | Option Exercise | $81.16 | 1,800 | 146,090 | 16,801 | Dec 06, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 05, 2023 | Sale | $227.33 | 1,000 | 227,330 | 15,001 | Dec 06, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 04, 2023 | Sale | $218.87 | 1,800 | 393,964 | 16,001 | Dec 06, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Nov 30, 2023 | Option Exercise | $73.75 | 3,000 | 221,250 | 18,001 | Dec 01, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Nov 29, 2023 | Option Exercise | $73.75 | 4,000 | 295,000 | 19,001 | Dec 01, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Nov 30, 2023 | Sale | $204.58 | 3,000 | 613,730 | 17,001 | Dec 01, 2023, 04:30 PM |
Lynch Brian Joseph | SVP and General Counsel | Nov 29, 2023 | Sale | $199.19 | 4,000 | 796,750 | 18,001 | Dec 01, 2023, 04:30 PM |
BAKER BROS. ADVISORS LP | Director | Nov 21, 2023 | Buy | $188.47 | 64,350 | 12,128,340 | 1,667,104 | Nov 21, 2023, 06:15 PM |
BAKER BROS. ADVISORS LP | Director | Nov 17, 2023 | Buy | $174.70 | 46,370 | 8,100,704 | 1,588,541 | Nov 21, 2023, 06:14 PM |
BAKER BROS. ADVISORS LP | Director | Nov 20, 2023 | Buy | $185.74 | 20,709 | 3,846,575 | 1,607,668 | Nov 21, 2023, 06:14 PM |
BAKER BROS. ADVISORS LP | Director | Nov 15, 2023 | Buy | $161.97 | 15,199 | 2,461,721 | 1,545,775 | Nov 15, 2023, 05:13 PM |
BAKER BROS. ADVISORS LP | Director | Nov 14, 2023 | Buy | $156.42 | 34,188 | 5,347,837 | 1,531,757 | Nov 15, 2023, 05:13 PM |
BAKER BROS. ADVISORS LP | Director | Nov 14, 2023 | Buy | $154.00 | 37,660 | 5,799,653 | 1,500,227 | Nov 15, 2023, 05:12 PM |
BAKER BROS. ADVISORS LP | Director | Nov 13, 2023 | Buy | $143.21 | 69,839 | 10,001,368 | 1,465,494 | Nov 15, 2023, 05:12 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Mar 01, 2023 | Option Exercise | $87.92 | 5,000 | 439,600 | 10,667 | Mar 02, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Feb 28, 2023 | Option Exercise | $87.92 | 5,000 | 439,600 | 10,667 | Mar 02, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Feb 28, 2023 | Sale | $272.07 | 5,000 | 1,360,357 | 9,767 | Mar 02, 2023, 04:30 PM |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Mar 01, 2023 | Sale | $274.42 | 5,000 | 1,372,081 | 8,739 | Mar 02, 2023, 04:30 PM |
Levy Richard S | Director | Jan 17, 2023 | Option Exercise | $103.02 | 22,489 | 2,316,844 | 31,589 | Jan 19, 2023, 07:57 PM |
Levy Richard S | Director | Jan 17, 2023 | Sale | $293.15 | 22,489 | 6,592,686 | 31,489 | Jan 19, 2023, 07:57 PM |
Lynch Brian Joseph | SVP and General Counsel | Jan 03, 2023 | Option Exercise | $91.79 | 13,000 | 1,193,270 | 13,000 | Jan 06, 2023, 09:08 AM |
Lynch Brian Joseph | SVP and General Counsel | Jan 03, 2023 | Sale | $282.92 | 13,000 | 3,677,977 | 12,400 | Jan 06, 2023, 09:08 AM |
Lynch Brian Joseph | SVP and General Counsel | Dec 23, 2022 | Option Exercise | $91.79 | 7,000 | 642,530 | 7,000 | Dec 28, 2022, 08:00 PM |
Lynch Brian Joseph | SVP and General Counsel | Dec 23, 2022 | Sale | $274.18 | 7,000 | 1,919,231 | 6,500 | Dec 28, 2022, 08:00 PM |
Sukhija Remy | Chief Commercial Officer | Dec 23, 2022 | Option Exercise | $60.26 | 30,000 | 1,807,800 | 30,000 | Dec 28, 2022, 08:00 PM |
Sukhija Remy | Chief Commercial Officer | Dec 23, 2022 | Sale | $274.14 | 30,000 | 8,224,073 | 29,407 | Dec 28, 2022, 08:00 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 19, 2020 | Sale | $107.64 | 7,303 | 786,095 | 42,875 | Aug 19, 2020, 07:40 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 18, 2020 | Sale | $110.03 | 10,197 | 1,121,976 | 50,178 | Aug 19, 2020, 07:40 PM |
BAY CITY CAPITAL LLC | 10% Owner | Aug 17, 2020 | Sale | $110.73 | 12,500 | 1,384,125 | 60,375 | Aug 19, 2020, 07:40 PM |
CRAVES FRED B | Director | Aug 17, 2020 | Sale | $110.73 | 12,500 | 1,384,125 | 60,375 | Aug 19, 2020, 07:40 PM |
CRAVES FRED B | Director | Aug 19, 2020 | Sale | $107.64 | 7,303 | 786,095 | 42,875 | Aug 19, 2020, 07:40 PM |
CRAVES FRED B | Director | Aug 18, 2020 | Sale | $110.03 | 10,197 | 1,121,976 | 50,178 | Aug 19, 2020, 07:40 PM |
MILLIGAN DAVID V | Director | Nov 19, 2018 | Sale | $131.60 | 10,000 | 1,316,000 | 20,000 | Feb 26, 2020, 06:06 PM |
MILLIGAN DAVID V | Director | Nov 21, 2018 | Sale | $112.54 | 20,000 | 2,250,800 | 0 | Feb 26, 2020, 05:41 PM |
BAY CITY CAPITAL LLC | 10% Owner | Dec 13, 2019 | Sale | $105.47 | 1,200,000 | 126,564,001 | 4,089,702 | Dec 13, 2019, 02:18 PM |
CRAVES FRED B | Director | Dec 13, 2019 | Sale | $105.47 | 1,200,000 | 126,564,001 | 4,089,702 | Dec 13, 2019, 02:08 PM |
CRAVES FRED B | Director | Jun 11, 2018 | Sale | $287.46 | 5,908 | 1,698,314 | 113,472 | Dec 13, 2019, 01:41 PM |
FRIEDMAN PAUL A | Chief Executive Officer | Nov 20, 2018 | Buy | $117.88 | 4,000 | 471,520 | 161,128 | Nov 23, 2018, 08:53 PM |
FRIEDMAN PAUL A | Chief Executive Officer | Nov 19, 2018 | Buy | $124.00 | 4,000 | 496,000 | 157,128 | Nov 19, 2018, 06:26 PM |
CRAVES FRED B | Director | Nov 19, 2018 | Buy | $124.69 | 2,000 | 249,387 | 298,067 | Nov 19, 2018, 06:09 PM |
MILLIGAN DAVID V | Director | Nov 14, 2018 | Option Exercise | $16.46 | 10,000 | 164,600 | 30,000 | Nov 14, 2018, 06:43 PM |
MILLIGAN DAVID V | Director | Sep 18, 2018 | Option Exercise | $9.45 | 20,000 | 189,000 | 20,000 | Sep 19, 2018, 04:25 PM |
Schneebaum Marc R | Chief Financial Officer | Jun 11, 2018 | Option Exercise | $86.64 | 7,957 | 689,409 | 51,767 | Jun 13, 2018, 03:53 PM |
Schneebaum Marc R | Chief Financial Officer | Jun 11, 2018 | Sale | $287.46 | 10,099 | 2,903,058 | 41,668 | Jun 13, 2018, 03:53 PM |
CRAVES FRED B | Director | Jun 11, 2018 | Sale | $287.46 | 280,000 | 80,488,798 | 5,264,382 | Jun 12, 2018, 09:02 PM |
FRIEDMAN PAUL A | Chief Executive Officer | Jun 11, 2018 | Sale | $287.46 | 73,526 | 21,135,783 | 655,540 | Jun 12, 2018, 08:56 PM |
Taub Rebecca | Chief Medical Officer, EVP R&D | Jun 11, 2018 | Sale | $287.46 | 73,526 | 21,135,783 | 655,540 | Jun 12, 2018, 08:55 PM |
BAY CITY CAPITAL LLC | Director | Jun 11, 2018 | Sale | $287.46 | 280,000 | 80,488,798 | 5,264,382 | Jun 12, 2018, 08:50 PM |
Levy Richard S | Director | Aug 23, 2017 | Buy | $16.12 | 2,000 | 32,236 | 9,100 | Aug 24, 2017, 04:04 PM |
Levy Richard S | Director | Aug 22, 2017 | Buy | $16.12 | 3,550 | 57,209 | 7,100 | Aug 23, 2017, 04:03 PM |
Levy Richard S | Director | Aug 21, 2017 | Buy | $15.88 | 3,550 | 56,358 | 3,550 | Aug 22, 2017, 04:05 PM |
Schor Chen | Former President and CEO | Jul 22, 2016 | Option Exercise | $9.48 | 14,250 | 135,090 | 37,178 | Jul 22, 2016, 05:23 PM |
Schneebaum Marc R | SVP and CFO | Jul 22, 2016 | Option Exercise | $9.48 | 8,548 | 81,035 | 19,308 | Jul 22, 2016, 05:22 PM |
Rieder Wendy E | Former SVP, Gen. Counsel | Jul 22, 2016 | Option Exercise | $9.48 | 8,550 | 81,054 | 17,730 | Jul 22, 2016, 05:18 PM |
Gollust Keith R | Director | Dec 14, 2015 | Sale | $0.32 | 300,000 | 96,690 | 1,539,169 | Dec 15, 2015, 04:34 PM |
Gollust Keith R | Director | Dec 11, 2015 | Sale | $0.37 | 300,000 | 111,030 | 1,839,169 | Dec 15, 2015, 04:34 PM |
Gollust Keith R | Director | Dec 09, 2015 | Sale | $0.38 | 145,892 | 55,235 | 2,139,169 | Dec 09, 2015, 05:00 PM |
Gollust Keith R | Director | Dec 08, 2015 | Sale | $0.38 | 300,000 | 114,060 | 2,285,061 | Dec 09, 2015, 05:00 PM |
Gollust Keith R | Director | Dec 07, 2015 | Sale | $0.39 | 300,000 | 115,830 | 2,585,061 | Dec 09, 2015, 05:00 PM |
Kovner Bruce | Director | Dec 08, 2015 | Sale | $0.37 | 496,015 | 183,526 | 340,970 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 08, 2015 | Sale | $0.37 | 873,624 | 323,241 | 600,548 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 07, 2015 | Sale | $0.41 | 36 | 15 | 836,985 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 07, 2015 | Sale | $0.41 | 64 | 26 | 1,474,172 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 04, 2015 | Sale | $0.41 | 55,629 | 22,941 | 837,021 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 04, 2015 | Sale | $0.41 | 97,978 | 40,406 | 1,474,236 | Dec 08, 2015, 02:09 PM |
Kovner Bruce | Director | Dec 03, 2015 | Sale | $0.41 | 167,394 | 69,284 | 1,572,214 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 02, 2015 | Sale | $0.43 | 249,015 | 106,379 | 987,690 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 02, 2015 | Sale | $0.43 | 438,588 | 187,365 | 1,739,608 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 01, 2015 | Sale | $0.43 | 174,091 | 74,894 | 1,236,705 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 01, 2015 | Sale | $0.43 | 306,625 | 131,910 | 2,178,196 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Dec 03, 2015 | Sale | $0.41 | 95,040 | 39,337 | 892,650 | Dec 03, 2015, 05:49 PM |
Kovner Bruce | Director | Nov 27, 2015 | Sale | $0.50 | 338,463 | 167,539 | 1,642,755 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 27, 2015 | Sale | $0.50 | 596,132 | 295,085 | 2,893,367 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 25, 2015 | Sale | $0.49 | 544,571 | 265,805 | 1,981,218 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 25, 2015 | Sale | $0.49 | 959,149 | 468,161 | 3,489,499 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 30, 2015 | Sale | $0.43 | 231,959 | 100,554 | 1,410,796 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 30, 2015 | Sale | $0.43 | 408,546 | 177,105 | 2,484,821 | Nov 30, 2015, 05:23 PM |
Kovner Bruce | Director | Nov 24, 2015 | Sale | $0.44 | 194,883 | 86,002 | 2,525,789 | Nov 24, 2015, 05:27 PM |
Kovner Bruce | Director | Nov 24, 2015 | Sale | $0.44 | 343,246 | 151,474 | 4,448,648 | Nov 24, 2015, 05:27 PM |
Kovner Bruce | Director | Nov 23, 2015 | Sale | $0.44 | 230,129 | 100,543 | 2,720,672 | Nov 24, 2015, 05:27 PM |
Kovner Bruce | Director | Nov 23, 2015 | Sale | $0.44 | 405,324 | 177,086 | 4,791,894 | Nov 24, 2015, 05:27 PM |
Kovner Bruce | Director | Nov 19, 2015 | Sale | $0.46 | 65,802 | 30,381 | 3,034,198 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 19, 2015 | Sale | $0.46 | 115,896 | 53,509 | 5,344,104 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 19, 2015 | Sale | $0.50 | 992,953 | 501,441 | 0 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 18, 2015 | Sale | $0.43 | 108,154 | 46,820 | 992,953 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 20, 2015 | Sale | $0.44 | 83,397 | 36,953 | 2,950,801 | Nov 20, 2015, 05:42 PM |
Kovner Bruce | Director | Nov 20, 2015 | Sale | $0.44 | 146,886 | 65,085 | 5,197,218 | Nov 20, 2015, 05:42 PM |
Gollust Keith R | Director | Nov 17, 2015 | Sale | $0.41 | 100,000 | 41,400 | 2,885,061 | Nov 19, 2015, 06:03 PM |
Kovner Bruce | Director | Nov 16, 2015 | Sale | $0.44 | 15,530 | 6,759 | 1,801,725 | Nov 17, 2015, 05:08 PM |
Kovner Bruce | Director | Nov 13, 2015 | Sale | $0.43 | 507,788 | 219,568 | 1,817,255 | Nov 17, 2015, 05:08 PM |
Kovner Bruce | Director | Nov 17, 2015 | Sale | $0.42 | 700,618 | 295,661 | 1,101,107 | Nov 17, 2015, 05:08 PM |
Gollust Keith R | Director | Nov 10, 2015 | Sale | $0.55 | 188,322 | 103,050 | 2,985,061 | Nov 13, 2015, 11:20 AM |
Gollust Keith R | Director | Nov 10, 2015 | Sale | $0.55 | 188,322 | 103,050 | 2,985,061 | Nov 12, 2015, 06:00 PM |
Kovner Bruce | Director | Nov 10, 2015 | Sale | $0.55 | 1,397,114 | 769,111 | 4,139,548 | Nov 12, 2015, 05:19 PM |
Kovner Bruce | Director | Nov 09, 2015 | Sale | $0.61 | 2,225,054 | 1,354,168 | 5,536,662 | Nov 12, 2015, 05:19 PM |
Kovner Bruce | Director | Nov 12, 2015 | Sale | $0.47 | 733,564 | 347,783 | 2,325,043 | Nov 12, 2015, 05:19 PM |
Kovner Bruce | Director | Nov 11, 2015 | Sale | $0.50 | 1,080,941 | 538,201 | 3,058,607 | Nov 12, 2015, 05:19 PM |
Kovner Bruce | Director | Apr 06, 2015 | Buy | $1.75 | 6,857,143 | 12,000,000 | 15,278,610 | Apr 08, 2015, 04:21 PM |
Gollust Keith R | Director | Apr 06, 2015 | Buy | $1.75 | 350,000 | 612,500 | 3,173,383 | Apr 08, 2015, 04:18 PM |
WILSON ROBERT N | Director | Apr 06, 2015 | Buy | $1.75 | 50,000 | 87,500 | 754,118 | Apr 08, 2015, 04:16 PM |
Kovner Bruce | Director | Sep 30, 2014 | Buy | $3.08 | 300,000 | 923,130 | 8,421,467 | Oct 01, 2014, 01:56 PM |
Kovner Bruce | Director | Apr 11, 2014 | Buy | $4.01 | 1,250,000 | 5,012,500 | 8,121,467 | Apr 14, 2014, 07:34 PM |
Bernitz Steven B | SVP, Corporate Development | Dec 18, 2013 | Option Exercise | $0.00 | 25,000 | 2 | 25,000 | Dec 20, 2013, 04:23 PM |
Bahcall Safi R | President and CEO | Nov 13, 2013 | Buy | $3.75 | 20,000 | 75,000 | 2,053,135 | Nov 15, 2013, 06:03 PM |
REARDON WILLIAM S | Director | Nov 13, 2013 | Buy | $3.75 | 13,333 | 49,999 | 36,561 | Nov 15, 2013, 06:01 PM |
Gollust Keith R | Director | Nov 13, 2013 | Buy | $3.75 | 150,000 | 562,500 | 2,823,383 | Nov 15, 2013, 05:58 PM |
Kovner Bruce | Director | Nov 13, 2013 | Buy | $3.75 | 3,400,000 | 12,750,000 | 7,649,803 | Nov 15, 2013, 05:56 PM |
Kovner Bruce | Director | Nov 13, 2013 | Buy | $3.75 | 1,600,000 | 6,000,000 | 1,600,000 | Nov 15, 2013, 05:56 PM |
Kovner Bruce | Director | Jun 27, 2013 | Buy | $4.71 | 150,000 | 706,515 | 3,100,000 | Jul 01, 2013, 05:55 PM |
Bahcall Safi R | President and CEO | Jun 28, 2013 | Buy | $5.03 | 10,000 | 50,299 | 2,033,135 | Jul 01, 2013, 08:28 AM |
Kovner Bruce | Director | Jun 26, 2013 | Buy | $4.65 | 300,000 | 1,395,930 | 2,950,000 | Jun 27, 2013, 05:52 PM |
Kovner Bruce | Director | Jun 25, 2013 | Buy | $4.35 | 200,000 | 869,460 | 2,650,000 | Jun 27, 2013, 05:52 PM |
Kovner Bruce | Director | Jun 24, 2013 | Buy | $4.43 | 200,000 | 885,920 | 2,450,000 | Jun 25, 2013, 04:42 PM |
Kovner Bruce | Director | Jun 21, 2013 | Buy | $4.23 | 50,000 | 211,520 | 2,250,000 | Jun 25, 2013, 04:42 PM |
Bahcall Safi R | President and CEO | Jun 21, 2013 | Buy | $4.12 | 20,000 | 82,374 | 2,023,135 | Jun 24, 2013, 08:01 AM |
Kovner Bruce | Director | Jun 18, 2013 | Buy | $4.00 | 200,000 | 799,160 | 2,200,000 | Jun 20, 2013, 04:44 PM |
Bahcall Safi R | President and CEO | Jun 14, 2013 | Buy | $4.05 | 10,000 | 40,550 | 2,003,135 | Jun 17, 2013, 08:02 AM |
Bahcall Safi R | President and CEO | Jun 06, 2013 | Buy | $4.04 | 10,000 | 40,390 | 1,993,135 | Jun 06, 2013, 05:19 PM |
Kovner Bruce | Director | Jun 04, 2013 | Buy | $4.99 | 505,100 | 2,521,661 | 505,100 | Jun 06, 2013, 05:10 PM |
Kovner Bruce | Director | Jun 06, 2013 | Buy | $4.31 | 738,900 | 3,186,949 | 2,000,000 | Jun 06, 2013, 05:10 PM |
Kovner Bruce | Director | Jun 05, 2013 | Buy | $4.71 | 756,000 | 3,561,743 | 1,261,100 | Jun 06, 2013, 05:10 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Jun 05, 2013 | Buy | $4.58 | 10,000 | 45,800 | 35,249 | Jun 06, 2013, 05:04 PM |
WILSON ROBERT N | Director | Jun 04, 2013 | Buy | $5.00 | 10,000 | 50,000 | 699,679 | Jun 06, 2013, 05:01 PM |
Ramachandra Sumant | President, R&D | Mar 11, 2013 | Option Exercise | $0.00 | 75,000 | 7 | 75,000 | Mar 13, 2013, 05:53 PM |
Gollust Keith R | Director | Jan 23, 2013 | Option Exercise | $8.66 | 114,250 | 989,603 | 316,255 | Jan 24, 2013, 04:59 PM |
WILSON ROBERT N | Director | Dec 12, 2012 | Option Exercise | $8.60 | 58,140 | 500,004 | 689,679 | Dec 14, 2012, 04:47 PM |
KUFE DONALD W | Director | Dec 12, 2012 | Option Exercise | $8.60 | 5,814 | 50,000 | 17,748 | Dec 14, 2012, 04:45 PM |
Kovner Bruce | Director | Dec 12, 2012 | Option Exercise | $8.60 | 2,325,581 | 19,999,997 | 3,273,281 | Dec 14, 2012, 04:43 PM |
Gollust Keith R | Director | Dec 12, 2012 | Option Exercise | $8.60 | 175,000 | 1,505,000 | 175,000 | Dec 14, 2012, 04:41 PM |
Gollust Keith R | Director | Dec 12, 2012 | Option Exercise | $8.60 | 75,000 | 645,000 | 2,673,383 | Dec 14, 2012, 04:41 PM |
Bahcall Safi R | President and CEO | Dec 12, 2012 | Option Exercise | $8.60 | 10,000 | 86,000 | 2,383,135 | Dec 14, 2012, 04:39 PM |
Singh Amar | Sr. VP, Chief Business Officer | Nov 29, 2012 | Option Exercise | $8.21 | 3,969 | 32,585 | 21,031 | Dec 03, 2012, 04:50 PM |
Kovner Bruce | Director | Nov 12, 2012 | Buy | $6.89 | 27,200 | 187,449 | 937,200 | Nov 14, 2012, 06:45 PM |
Kovner Bruce | Director | Nov 14, 2012 | Buy | $6.95 | 10,500 | 73,009 | 947,700 | Nov 14, 2012, 06:45 PM |
Bahcall Safi R | President and CEO | Nov 12, 2012 | Buy | $7.12 | 10,000 | 71,200 | 2,373,135 | Nov 13, 2012, 09:06 AM |
KUFE DONALD W | Director | Jul 25, 2012 | Option Exercise | $6.49 | 4,622 | 29,997 | 11,934 | Jul 27, 2012, 04:41 PM |
WILSON ROBERT N | Director | Jul 25, 2012 | Option Exercise | $6.49 | 100,000 | 649,000 | 631,539 | Jul 27, 2012, 04:40 PM |
Kovner Bruce | Director | Jul 25, 2012 | Option Exercise | $6.49 | 3,081,664 | 19,999,999 | 8,006,852 | Jul 27, 2012, 04:38 PM |
Gollust Keith R | Director | Jul 25, 2012 | Option Exercise | $6.49 | 770,416 | 5,000,000 | 2,598,383 | Jul 27, 2012, 04:36 PM |
Bahcall Safi R | President and CEO | Jul 25, 2012 | Option Exercise | $6.49 | 20,000 | 129,800 | 2,363,135 | Jul 27, 2012, 04:34 PM |
Kovner Bruce | Director | Jun 29, 2012 | Buy | $5.45 | 910,000 | 4,959,318 | 6,816,048 | Jul 02, 2012, 04:53 PM |
Gollust Keith R | Director | Jun 29, 2012 | Buy | $5.35 | 150,000 | 801,900 | 1,827,967 | Jul 02, 2012, 02:45 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Jun 29, 2012 | Buy | $5.59 | 3,000 | 16,755 | 25,249 | Jul 02, 2012, 08:53 AM |
Bahcall Safi R | President and CEO | Jun 29, 2012 | Buy | $5.34 | 10,000 | 53,370 | 2,343,135 | Jul 02, 2012, 08:53 AM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Jun 18, 2012 | Option Exercise | $2.49 | 7,170 | 17,853 | 26,993 | Jun 20, 2012, 04:08 PM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Jun 18, 2012 | Sale | $6.00 | 7,170 | 43,020 | 19,823 | Jun 20, 2012, 04:08 PM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Jun 04, 2012 | Option Exercise | $2.49 | 7,170 | 17,853 | 26,993 | Jun 06, 2012, 04:23 PM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Jun 04, 2012 | Sale | $5.50 | 7,170 | 39,435 | 19,823 | Jun 06, 2012, 04:23 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Mar 01, 2012 | Sale | $4.70 | 2,555 | 12,006 | 22,249 | Mar 05, 2012, 04:13 PM |
Koya Keizo | Sr. VP, Drug Development | Mar 01, 2012 | Sale | $4.70 | 6,844 | 32,187 | 12,999 | Mar 05, 2012, 04:12 PM |
Ehrlich Keith S | VP, Fin. and Admin., CFO | Mar 01, 2012 | Sale | $4.70 | 4,397 | 20,662 | 17,573 | Mar 05, 2012, 04:12 PM |
Kovner Bruce | Director | Jan 06, 2012 | Buy | $4.40 | 1,136,363 | 4,999,997 | 5,906,048 | Jan 10, 2012, 04:11 PM |
Kovner Bruce | Director | Dec 07, 2011 | Buy | $3.95 | 11,059 | 43,727 | 5,269,685 | Dec 09, 2011, 04:32 PM |
Kovner Bruce | Director | Nov 29, 2011 | Buy | $3.96 | 8,844 | 35,024 | 5,258,626 | Dec 01, 2011, 04:29 PM |
Kovner Bruce | Director | Nov 25, 2011 | Buy | $3.94 | 25,016 | 98,473 | 5,249,782 | Nov 29, 2011, 04:54 PM |
Kovner Bruce | Director | Nov 23, 2011 | Buy | $3.98 | 7,547 | 30,039 | 5,224,766 | Nov 25, 2011, 04:12 PM |
Kovner Bruce | Director | Nov 22, 2011 | Buy | $3.96 | 453 | 1,793 | 5,217,219 | Nov 25, 2011, 04:12 PM |
Kovner Bruce | Director | Nov 21, 2011 | Buy | $3.84 | 33,640 | 129,299 | 5,216,766 | Nov 22, 2011, 04:44 PM |
Kovner Bruce | Director | Nov 18, 2011 | Buy | $3.71 | 21,000 | 77,921 | 5,183,126 | Nov 22, 2011, 04:44 PM |
Kovner Bruce | Director | Sep 12, 2011 | Buy | $3.82 | 43,085 | 164,455 | 5,162,126 | Sep 13, 2011, 04:06 PM |
Kovner Bruce | Director | Sep 09, 2011 | Buy | $3.77 | 110,149 | 415,702 | 5,119,041 | Sep 13, 2011, 04:06 PM |
Kovner Bruce | Director | Sep 06, 2011 | Buy | $3.79 | 50,400 | 191,258 | 5,008,892 | Sep 07, 2011, 04:56 PM |
Kovner Bruce | Director | Sep 02, 2011 | Buy | $3.89 | 46,057 | 179,245 | 4,958,492 | Sep 07, 2011, 04:56 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Sep 02, 2011 | Buy | $4.00 | 2,188 | 8,752 | 24,804 | Sep 06, 2011, 04:27 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Sep 01, 2011 | Buy | $4.07 | 312 | 1,270 | 22,616 | Sep 06, 2011, 04:27 PM |
Kovner Bruce | Director | Aug 26, 2011 | Buy | $3.85 | 100 | 385 | 4,912,435 | Aug 30, 2011, 04:12 PM |
Kovner Bruce | Director | Aug 23, 2011 | Buy | $3.72 | 5,167 | 19,225 | 4,912,335 | Aug 24, 2011, 04:36 PM |
Kovner Bruce | Director | Aug 22, 2011 | Buy | $3.77 | 10,597 | 39,963 | 4,907,168 | Aug 24, 2011, 04:36 PM |
Kovner Bruce | Director | Aug 18, 2011 | Buy | $3.79 | 3,303 | 12,510 | 4,896,569 | Aug 22, 2011, 04:20 PM |
Kovner Bruce | Director | Aug 09, 2011 | Buy | $3.71 | 52,464 | 194,636 | 4,859,288 | Aug 10, 2011, 08:28 PM |
Kovner Bruce | Director | Aug 08, 2011 | Buy | $3.77 | 41,700 | 157,347 | 4,806,824 | Aug 10, 2011, 08:28 PM |
Kovner Bruce | Director | Aug 10, 2011 | Buy | $3.70 | 33,978 | 125,593 | 4,893,266 | Aug 10, 2011, 08:28 PM |
Koya Keizo | Sr. VP, Drug Development | Apr 25, 2011 | Sale | $6.00 | 10,000 | 60,000 | 19,843 | Apr 26, 2011, 09:44 PM |
Koya Keizo | Sr. VP, Drug Development | Apr 20, 2011 | Sale | $5.60 | 10,000 | 56,000 | 29,843 | Apr 26, 2011, 09:44 PM |
WILSON ROBERT N | Director | Apr 14, 2011 | Buy | $4.89 | 50,000 | 244,500 | 522,399 | Apr 18, 2011, 04:09 PM |
Gollust Keith R | Director | Apr 14, 2011 | Buy | $4.89 | 100,000 | 489,000 | 1,677,967 | Apr 18, 2011, 04:05 PM |
Kovner Bruce | Director | Apr 14, 2011 | Buy | $4.89 | 1,431,493 | 7,000,001 | 4,757,266 | Apr 18, 2011, 04:05 PM |
Bahcall Safi R | President and CEO | Mar 15, 2011 | Buy | $4.45 | 5,000 | 22,250 | 2,333,135 | Mar 15, 2011, 02:56 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Mar 01, 2011 | Sale | $5.32 | 2,617 | 13,928 | 15,004 | Mar 03, 2011, 04:33 PM |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | Mar 01, 2011 | Sale | $5.25 | 5,284 | 27,762 | 15,426 | Mar 03, 2011, 04:30 PM |
Ehrlich Keith S | VP, Fin. and Admin., CFO | Mar 01, 2011 | Sale | $5.51 | 2,537 | 13,966 | 17,573 | Mar 03, 2011, 04:26 PM |
Koya Keizo | Sr. VP, Drug Development | Mar 01, 2011 | Sale | $5.23 | 18,270 | 95,552 | 32,999 | Mar 03, 2011, 04:20 PM |
Kovner Bruce | Director | Nov 10, 2010 | Option Exercise | $3.47 | 1,440,923 | 5,000,003 | 3,325,773 | Nov 12, 2010, 04:26 PM |
Kovner Bruce | Director | Sep 15, 2010 | Buy | $3.64 | 24,264 | 88,411 | 1,884,850 | Sep 17, 2010, 04:15 PM |
Kovner Bruce | Director | Sep 14, 2010 | Buy | $3.70 | 38,836 | 143,650 | 1,860,586 | Sep 15, 2010, 04:10 PM |
Kovner Bruce | Director | Sep 13, 2010 | Buy | $3.57 | 36,900 | 131,855 | 1,821,750 | Sep 15, 2010, 04:10 PM |
Vukovic Vojo | SVP, Chief Medical Officer | Aug 16, 2010 | Buy | $2.95 | 2,800 | 8,260 | 17,621 | Aug 20, 2010, 10:32 AM |
Vukovic Vojo | SVP, Chief Medical Officer | Aug 12, 2010 | Buy | $2.84 | 714 | 2,028 | 14,821 | Aug 20, 2010, 10:32 AM |
BAILEY MICHAEL P | Sr. VP, Chief Comm. Officer | Aug 05, 2010 | Sale | $3.21 | 4,000 | 12,840 | 29,627 | Aug 06, 2010, 04:41 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Lynch Brian Joseph | SVP and General Counsel | 01/16/2024 | 231,480 |
FRIEDMAN PAUL A | Director | 01/16/2023 | 549,796 |
Taub Rebecca | Pres., R&D, and CMO | 01/16/2024 | 377,100 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 01/16/2024 | 134,156 |
Howarth Alex G. | Chief Financial Officer | 01/16/2024 | 260,263 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/15/2023 | 175,840 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/14/2023 | 175,840 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/14/2023 | 465,000 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/15/2023 | 477,000 |
BAKER BROS. ADVISORS LP | Director | 12/14/2023 | 4,710,893 |
BAKER BROS. ADVISORS LP | Director | 12/13/2023 | 17,805,684 |
BAKER BROS. ADVISORS LP | Director | 12/12/2023 | 7,548,616 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/13/2023 | 219,800 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/12/2023 | 114,296 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/13/2023 | 563,500 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 12/12/2023 | 283,200 |
Lynch Brian Joseph | SVP and General Counsel | 12/05/2023 | 87,090 |
Lynch Brian Joseph | SVP and General Counsel | 12/04/2023 | 146,090 |
Lynch Brian Joseph | SVP and General Counsel | 12/05/2023 | 227,330 |
Lynch Brian Joseph | SVP and General Counsel | 12/04/2023 | 393,964 |
Lynch Brian Joseph | SVP and General Counsel | 11/30/2023 | 221,250 |
Lynch Brian Joseph | SVP and General Counsel | 11/29/2023 | 295,000 |
Lynch Brian Joseph | SVP and General Counsel | 11/30/2023 | 613,730 |
Lynch Brian Joseph | SVP and General Counsel | 11/29/2023 | 796,750 |
BAKER BROS. ADVISORS LP | Director | 11/21/2023 | 12,128,340 |
BAKER BROS. ADVISORS LP | Director | 11/17/2023 | 8,100,704 |
BAKER BROS. ADVISORS LP | Director | 11/20/2023 | 3,846,575 |
BAKER BROS. ADVISORS LP | Director | 11/15/2023 | 2,461,721 |
BAKER BROS. ADVISORS LP | Director | 11/14/2023 | 5,347,837 |
BAKER BROS. ADVISORS LP | Director | 11/14/2023 | 5,799,653 |
BAKER BROS. ADVISORS LP | Director | 11/13/2023 | 10,001,368 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 03/01/2023 | 439,600 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 02/28/2023 | 439,600 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 02/28/2023 | 1,360,357 |
Waltermire Robert E. | Senior VP, Chief Pharma Dev. | 03/01/2023 | 1,372,081 |
Levy Richard S | Director | 01/17/2023 | 2,316,844 |
Levy Richard S | Director | 01/17/2023 | 6,592,686 |
Lynch Brian Joseph | SVP and General Counsel | 01/03/2023 | 1,193,270 |
Lynch Brian Joseph | SVP and General Counsel | 01/03/2023 | 3,677,977 |
Lynch Brian Joseph | SVP and General Counsel | 12/23/2022 | 642,530 |
Lynch Brian Joseph | SVP and General Counsel | 12/23/2022 | 1,919,231 |
Sukhija Remy | Chief Commercial Officer | 12/23/2022 | 1,807,800 |
Sukhija Remy | Chief Commercial Officer | 12/23/2022 | 8,224,073 |
BAY CITY CAPITAL LLC | 10% Owner | 08/19/2020 | 786,095 |
BAY CITY CAPITAL LLC | 10% Owner | 08/18/2020 | 1,121,976 |
BAY CITY CAPITAL LLC | 10% Owner | 08/17/2020 | 1,384,125 |
CRAVES FRED B | Director | 08/17/2020 | 1,384,125 |
CRAVES FRED B | Director | 08/19/2020 | 786,095 |
CRAVES FRED B | Director | 08/18/2020 | 1,121,976 |
MILLIGAN DAVID V | Director | 11/19/2018 | 1,316,000 |
MILLIGAN DAVID V | Director | 11/21/2018 | 2,250,800 |
BAY CITY CAPITAL LLC | 10% Owner | 12/13/2019 | 126,564,001 |
CRAVES FRED B | Director | 12/13/2019 | 126,564,001 |
CRAVES FRED B | Director | 06/11/2018 | 1,698,314 |
FRIEDMAN PAUL A | Chief Executive Officer | 11/20/2018 | 471,520 |
FRIEDMAN PAUL A | Chief Executive Officer | 11/19/2018 | 496,000 |
CRAVES FRED B | Director | 11/19/2018 | 249,387 |
MILLIGAN DAVID V | Director | 11/14/2018 | 164,600 |
MILLIGAN DAVID V | Director | 09/18/2018 | 189,000 |
Schneebaum Marc R | Chief Financial Officer | 06/11/2018 | 689,409 |
Schneebaum Marc R | Chief Financial Officer | 06/11/2018 | 2,903,058 |
CRAVES FRED B | Director | 06/11/2018 | 80,488,798 |
FRIEDMAN PAUL A | Chief Executive Officer | 06/11/2018 | 21,135,783 |
Taub Rebecca | Chief Medical Officer, EVP R&D | 06/11/2018 | 21,135,783 |
BAY CITY CAPITAL LLC | Director | 06/11/2018 | 80,488,798 |
Levy Richard S | Director | 08/23/2017 | 32,236 |
Levy Richard S | Director | 08/22/2017 | 57,209 |
Levy Richard S | Director | 08/21/2017 | 56,358 |
Schor Chen | Former President and CEO | 07/22/2016 | 135,090 |
Schneebaum Marc R | SVP and CFO | 07/22/2016 | 81,035 |
Rieder Wendy E | Former SVP, Gen. Counsel | 07/22/2016 | 81,054 |
Gollust Keith R | Director | 12/14/2015 | 96,690 |
Gollust Keith R | Director | 12/11/2015 | 111,030 |
Gollust Keith R | Director | 12/09/2015 | 55,235 |
Gollust Keith R | Director | 12/08/2015 | 114,060 |
Gollust Keith R | Director | 12/07/2015 | 115,830 |
Kovner Bruce | Director | 12/08/2015 | 183,526 |
Kovner Bruce | Director | 12/08/2015 | 323,241 |
Kovner Bruce | Director | 12/07/2015 | 15 |
Kovner Bruce | Director | 12/07/2015 | 26 |
Kovner Bruce | Director | 12/04/2015 | 22,941 |
Kovner Bruce | Director | 12/04/2015 | 40,406 |
Kovner Bruce | Director | 12/03/2015 | 69,284 |
Kovner Bruce | Director | 12/02/2015 | 106,379 |
Kovner Bruce | Director | 12/02/2015 | 187,365 |
Kovner Bruce | Director | 12/01/2015 | 74,894 |
Kovner Bruce | Director | 12/01/2015 | 131,910 |
Kovner Bruce | Director | 12/03/2015 | 39,337 |
Kovner Bruce | Director | 11/27/2015 | 167,539 |
Kovner Bruce | Director | 11/27/2015 | 295,085 |
Kovner Bruce | Director | 11/25/2015 | 265,805 |
Kovner Bruce | Director | 11/25/2015 | 468,161 |
Kovner Bruce | Director | 11/30/2015 | 100,554 |
Kovner Bruce | Director | 11/30/2015 | 177,105 |
Kovner Bruce | Director | 11/24/2015 | 86,002 |
Kovner Bruce | Director | 11/24/2015 | 151,474 |
Kovner Bruce | Director | 11/23/2015 | 100,543 |
Kovner Bruce | Director | 11/23/2015 | 177,086 |
Kovner Bruce | Director | 11/19/2015 | 30,381 |
Kovner Bruce | Director | 11/19/2015 | 53,509 |
Kovner Bruce | Director | 11/19/2015 | 501,441 |
Kovner Bruce | Director | 11/18/2015 | 46,820 |
Kovner Bruce | Director | 11/20/2015 | 36,953 |
Kovner Bruce | Director | 11/20/2015 | 65,085 |
Gollust Keith R | Director | 11/17/2015 | 41,400 |
Kovner Bruce | Director | 11/16/2015 | 6,759 |
Kovner Bruce | Director | 11/13/2015 | 219,568 |
Kovner Bruce | Director | 11/17/2015 | 295,661 |
Gollust Keith R | Director | 11/10/2015 | 103,050 |
Gollust Keith R | Director | 11/10/2015 | 103,050 |
Kovner Bruce | Director | 11/10/2015 | 769,111 |
Kovner Bruce | Director | 11/09/2015 | 1,354,168 |
Kovner Bruce | Director | 11/12/2015 | 347,783 |
Kovner Bruce | Director | 11/11/2015 | 538,201 |
Kovner Bruce | Director | 04/06/2015 | 12,000,000 |
Gollust Keith R | Director | 04/06/2015 | 612,500 |
WILSON ROBERT N | Director | 04/06/2015 | 87,500 |
Kovner Bruce | Director | 09/30/2014 | 923,130 |
Kovner Bruce | Director | 04/11/2014 | 5,012,500 |
Bernitz Steven B | SVP, Corporate Development | 12/18/2013 | 2 |
Bahcall Safi R | President and CEO | 11/13/2013 | 75,000 |
REARDON WILLIAM S | Director | 11/13/2013 | 49,999 |
Gollust Keith R | Director | 11/13/2013 | 562,500 |
Kovner Bruce | Director | 11/13/2013 | 12,750,000 |
Kovner Bruce | Director | 11/13/2013 | 6,000,000 |
Kovner Bruce | Director | 06/27/2013 | 706,515 |
Bahcall Safi R | President and CEO | 06/28/2013 | 50,299 |
Kovner Bruce | Director | 06/26/2013 | 1,395,930 |
Kovner Bruce | Director | 06/25/2013 | 869,460 |
Kovner Bruce | Director | 06/24/2013 | 885,920 |
Kovner Bruce | Director | 06/21/2013 | 211,520 |
Bahcall Safi R | President and CEO | 06/21/2013 | 82,374 |
Kovner Bruce | Director | 06/18/2013 | 799,160 |
Bahcall Safi R | President and CEO | 06/14/2013 | 40,550 |
Bahcall Safi R | President and CEO | 06/06/2013 | 40,390 |
Kovner Bruce | Director | 06/04/2013 | 2,521,661 |
Kovner Bruce | Director | 06/06/2013 | 3,186,949 |
Kovner Bruce | Director | 06/05/2013 | 3,561,743 |
Vukovic Vojo | SVP, Chief Medical Officer | 06/05/2013 | 45,800 |
WILSON ROBERT N | Director | 06/04/2013 | 50,000 |
Ramachandra Sumant | President, R&D | 03/11/2013 | 7 |
Gollust Keith R | Director | 01/23/2013 | 989,603 |
WILSON ROBERT N | Director | 12/12/2012 | 500,004 |
KUFE DONALD W | Director | 12/12/2012 | 50,000 |
Kovner Bruce | Director | 12/12/2012 | 19,999,997 |
Gollust Keith R | Director | 12/12/2012 | 1,505,000 |
Gollust Keith R | Director | 12/12/2012 | 645,000 |
Bahcall Safi R | President and CEO | 12/12/2012 | 86,000 |
Singh Amar | Sr. VP, Chief Business Officer | 11/29/2012 | 32,585 |
Kovner Bruce | Director | 11/12/2012 | 187,449 |
Kovner Bruce | Director | 11/14/2012 | 73,009 |
Bahcall Safi R | President and CEO | 11/12/2012 | 71,200 |
KUFE DONALD W | Director | 07/25/2012 | 29,997 |
WILSON ROBERT N | Director | 07/25/2012 | 649,000 |
Kovner Bruce | Director | 07/25/2012 | 19,999,999 |
Gollust Keith R | Director | 07/25/2012 | 5,000,000 |
Bahcall Safi R | President and CEO | 07/25/2012 | 129,800 |
Kovner Bruce | Director | 06/29/2012 | 4,959,318 |
Gollust Keith R | Director | 06/29/2012 | 801,900 |
Vukovic Vojo | SVP, Chief Medical Officer | 06/29/2012 | 16,755 |
Bahcall Safi R | President and CEO | 06/29/2012 | 53,370 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 06/18/2012 | 17,853 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 06/18/2012 | 43,020 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 06/04/2012 | 17,853 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 06/04/2012 | 39,435 |
Vukovic Vojo | SVP, Chief Medical Officer | 03/01/2012 | 12,006 |
Koya Keizo | Sr. VP, Drug Development | 03/01/2012 | 32,187 |
Ehrlich Keith S | VP, Fin. and Admin., CFO | 03/01/2012 | 20,662 |
Kovner Bruce | Director | 01/06/2012 | 4,999,997 |
Kovner Bruce | Director | 12/07/2011 | 43,727 |
Kovner Bruce | Director | 11/29/2011 | 35,024 |
Kovner Bruce | Director | 11/25/2011 | 98,473 |
Kovner Bruce | Director | 11/23/2011 | 30,039 |
Kovner Bruce | Director | 11/22/2011 | 1,793 |
Kovner Bruce | Director | 11/21/2011 | 129,299 |
Kovner Bruce | Director | 11/18/2011 | 77,921 |
Kovner Bruce | Director | 09/12/2011 | 164,455 |
Kovner Bruce | Director | 09/09/2011 | 415,702 |
Kovner Bruce | Director | 09/06/2011 | 191,258 |
Kovner Bruce | Director | 09/02/2011 | 179,245 |
Vukovic Vojo | SVP, Chief Medical Officer | 09/02/2011 | 8,752 |
Vukovic Vojo | SVP, Chief Medical Officer | 09/01/2011 | 1,270 |
Kovner Bruce | Director | 08/26/2011 | 385 |
Kovner Bruce | Director | 08/23/2011 | 19,225 |
Kovner Bruce | Director | 08/22/2011 | 39,963 |
Kovner Bruce | Director | 08/18/2011 | 12,510 |
Kovner Bruce | Director | 08/09/2011 | 194,636 |
Kovner Bruce | Director | 08/08/2011 | 157,347 |
Kovner Bruce | Director | 08/10/2011 | 125,593 |
Koya Keizo | Sr. VP, Drug Development | 04/25/2011 | 60,000 |
Koya Keizo | Sr. VP, Drug Development | 04/20/2011 | 56,000 |
WILSON ROBERT N | Director | 04/14/2011 | 244,500 |
Gollust Keith R | Director | 04/14/2011 | 489,000 |
Kovner Bruce | Director | 04/14/2011 | 7,000,001 |
Bahcall Safi R | President and CEO | 03/15/2011 | 22,250 |
Vukovic Vojo | SVP, Chief Medical Officer | 03/01/2011 | 13,928 |
Rieder Wendy E | VP, IP and Legal, Gen. Counsel | 03/01/2011 | 27,762 |
Ehrlich Keith S | VP, Fin. and Admin., CFO | 03/01/2011 | 13,966 |
Koya Keizo | Sr. VP, Drug Development | 03/01/2011 | 95,552 |
Kovner Bruce | Director | 11/10/2010 | 5,000,003 |
Kovner Bruce | Director | 09/15/2010 | 88,411 |
Kovner Bruce | Director | 09/14/2010 | 143,650 |
Kovner Bruce | Director | 09/13/2010 | 131,855 |
Vukovic Vojo | SVP, Chief Medical Officer | 08/16/2010 | 8,260 |
Vukovic Vojo | SVP, Chief Medical Officer | 08/12/2010 | 2,028 |
BAILEY MICHAEL P | Sr. VP, Chief Comm. Officer | 08/05/2010 | 12,840 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...